Related Experiment Video
Updated: May 26, 2026
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Changes in frailty and incident risk of degenerative bone and joint diseases and their multimorbidity: a prospective
Minghao Jin1, Jiawei Liu2, Xin Song1
1Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Background:
Frailty reflects multisystem physiological vulnerability and has been associated with an array of adverse health outcomes. However, evidence on how frailty and its longitudinal changes relate to degenerative bone and joint diseases (DBJDs) and their multimorbidity remains limited.
Methods:
We conducted a prospective cohort study using data from the UK Biobank (UKB). Frailty was evaluated using a validated frailty index (FI). Changes in frailty were characterized by frailty status transitions, the rate of change in FI (ΔFI), and cumulative burden (total FI). Incident DBJDs including osteoporosis, osteoarthritis, and intervertebral disc degeneration as well as degenerative bone and joint multimorbidity (DBJM) were ascertained through linkage to health records. Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (95%CIs).
Results:
Compared with baseline non-frail participants, frail individuals had substantially higher risks of both DBJDs (HR = 2.06, 95%CI = 2.01-2.11) and DBJM (HR = 3.89, 95%CI = 3.62-4.18), with pre-frail participants showing intermediate risks. In transitions analyses, compared with participants who remained stable, those who progressed to worse status had increased risks of DBJDs (non-frail → pre-frail/frail: HR = 1.33, 95%CI = 1.21-1.47; pre-frail → frail: HR = 1.39, 95%CI = 1.20-1.60). In contrast, frailty recovery from pre-frailty to non-frailty was associated with a decreased risk of DBJDs (HR = 0.80, 95%CI = 0.71-0.91), although evidence for frailty recovery was less consistent overall.
Conclusion:
Frailty status and its longitudinal changes are strongly associated with the risk of incident DBJDs and DBJM. Frailty progression and cumulative frailty burden confer substantially increased risks, while frailty recovery may be associated with a lower risk, although the evidence remains limited.
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:09Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
01:30Development of Human Microbiota
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age